Research statistics

Thymulin research: publications and trials

What has been published on Thymulin: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Thymulin works or is safe. For what it is and what the studies found, see the Thymulin profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

324

Since 1977

Publications in 2026 so far

1

Through November 15, 2026

Human clinical research

19.0%

59 of 311 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

3

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

72.7%

185 animal · 40 in vitro · 1 computational

Records that only mention it

115

Not counted above

Status in the library: Research only. Groups: Thymic peptides. 13 publications are not yet classified by study type.

What to keep in mind

  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

Thymulin publications by year and evidence

1977, Preclinical (animal, in vitro, computational): 1 of 11978, Other and not yet classified: 1 of 11979, Preclinical (animal, in vitro, computational): 2 of 41979, Other and not yet classified: 2 of 41980, Preclinical (animal, in vitro, computational): 7 of 91980, Other and not yet classified: 2 of 91981, Preclinical (animal, in vitro, computational): 3 of 41981, Other and not yet classified: 1 of 41982, Human clinical research: 2 of 111982, Preclinical (animal, in vitro, computational): 8 of 111982, Other and not yet classified: 1 of 111983, Human clinical research: 1 of 141983, Preclinical (animal, in vitro, computational): 13 of 141984, Human clinical research: 3 of 151984, Preclinical (animal, in vitro, computational): 9 of 151984, Reviews and meta-analyses: 2 of 151984, Other and not yet classified: 1 of 151985, Human clinical research: 2 of 101985, Preclinical (animal, in vitro, computational): 6 of 101985, Reviews and meta-analyses: 1 of 101985, Other and not yet classified: 1 of 101986, Human clinical research: 4 of 131986, Preclinical (animal, in vitro, computational): 9 of 131987, Human clinical research: 1 of 101987, Preclinical (animal, in vitro, computational): 7 of 101987, Other and not yet classified: 2 of 101988, Human clinical research: 3 of 141988, Preclinical (animal, in vitro, computational): 10 of 141988, Reviews and meta-analyses: 1 of 141989, Human clinical research: 4 of 121989, Preclinical (animal, in vitro, computational): 7 of 121989, Reviews and meta-analyses: 1 of 121990, Human clinical research: 7 of 201990, Preclinical (animal, in vitro, computational): 11 of 201990, Other and not yet classified: 2 of 201991, Human clinical research: 2 of 71991, Preclinical (animal, in vitro, computational): 4 of 71991, Other and not yet classified: 1 of 71992, Human clinical research: 5 of 151992, Preclinical (animal, in vitro, computational): 7 of 151992, Reviews and meta-analyses: 2 of 151992, Other and not yet classified: 1 of 151993, Human clinical research: 4 of 121993, Preclinical (animal, in vitro, computational): 7 of 121993, Reviews and meta-analyses: 1 of 121994, Human clinical research: 2 of 81994, Preclinical (animal, in vitro, computational): 5 of 81994, Reviews and meta-analyses: 1 of 81995, Human clinical research: 2 of 71995, Preclinical (animal, in vitro, computational): 5 of 71996, Human clinical research: 3 of 61996, Preclinical (animal, in vitro, computational): 3 of 61997, Human clinical research: 1 of 91997, Preclinical (animal, in vitro, computational): 7 of 91997, Reviews and meta-analyses: 1 of 91998, Preclinical (animal, in vitro, computational): 7 of 71999, Human clinical research: 1 of 101999, Preclinical (animal, in vitro, computational): 6 of 101999, Reviews and meta-analyses: 3 of 102000, Human clinical research: 4 of 102000, Preclinical (animal, in vitro, computational): 6 of 102001, Human clinical research: 1 of 62001, Preclinical (animal, in vitro, computational): 5 of 62002, Preclinical (animal, in vitro, computational): 10 of 102003, Preclinical (animal, in vitro, computational): 8 of 82004, Preclinical (animal, in vitro, computational): 4 of 52004, Reviews and meta-analyses: 1 of 52005, Human clinical research: 2 of 72005, Preclinical (animal, in vitro, computational): 5 of 72006, Preclinical (animal, in vitro, computational): 4 of 62006, Reviews and meta-analyses: 1 of 62006, Other and not yet classified: 1 of 62007, Human clinical research: 1 of 42007, Preclinical (animal, in vitro, computational): 3 of 42008, Preclinical (animal, in vitro, computational): 2 of 32008, Reviews and meta-analyses: 1 of 32009, Human clinical research: 1 of 42009, Preclinical (animal, in vitro, computational): 2 of 42009, Reviews and meta-analyses: 1 of 42010, Preclinical (animal, in vitro, computational): 2 of 42010, Reviews and meta-analyses: 2 of 42011, Human clinical research: 1 of 52011, Preclinical (animal, in vitro, computational): 3 of 52011, Reviews and meta-analyses: 1 of 52012, Preclinical (animal, in vitro, computational): 4 of 52012, Reviews and meta-analyses: 1 of 52013, Preclinical (animal, in vitro, computational): 4 of 42014, Human clinical research: 1 of 62014, Preclinical (animal, in vitro, computational): 4 of 62014, Reviews and meta-analyses: 1 of 62015, Preclinical (animal, in vitro, computational): 5 of 52016, Preclinical (animal, in vitro, computational): 1 of 12017, Preclinical (animal, in vitro, computational): 2 of 22018, Preclinical (animal, in vitro, computational): 1 of 22018, Reviews and meta-analyses: 1 of 22019, Human clinical research: 1 of 32019, Preclinical (animal, in vitro, computational): 2 of 32020, Preclinical (animal, in vitro, computational): 2 of 22021, Preclinical (animal, in vitro, computational): 1 of 12023, Preclinical (animal, in vitro, computational): 1 of 12026 (to date), Preclinical (animal, in vitro, computational): 1 of 1Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0510152019771987199720072026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197701001
197800011
197902024
198007029
198103014
1982280111
19831130014
1984392115
1985261110
1986490013
1987170210
19883101014
1989471012
19907110220
199124017
1992572115
1993471012
199425108
199525007
199633006
199717109
199807007
1999163010
2000460010
200115006
20020100010
200308008
200404105
200525007
200604116
200713004
200802103
200912104
201002204
201113105
201204105
201304004
201414106
201505005
201601001
201702002
201801102
201912003
202002002
202101001
202301001
2026 (to date)01001

Study types

Animal study185
In vitro study40
Observational human study36
Review23
Other clinical trial19
Not yet classified13
Editorial, letter or other3
Randomized controlled trial3
Case report1
Computational study1

Research areas

From MeSH major topics. A paper can be in several areas.

Immune system185
Endocrinology76
Neurological and mental health65
Longevity and aging36
Oncology23
Antimicrobial and infectious disease18
Reproductive and sexual health15
Metabolic health11
Musculoskeletal10
Gastrointestinal6
Tissue repair4
Cognitive health3

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Prenatal and childhood exposures are associated with thymulin concentrations in young adolescent children in rural Nepal.

    Journal of developmental origins of health and disease · September 2, 2019 · Randomized controlled trial · cited 4 times

    PMID 31475652 · DOI 10.1017/s2040174419000485 · Human clinical research

  2. Effects of zinc-fortified drinking skim milk (as functional food) on cytokine release and thymic hormone activity in very old persons: a pilot study.

    Age (Dordrecht, Netherlands) · April 26, 2014 · Randomized controlled trial · cited 19 times · open access

    PMID 24771015 · DOI 10.1007/s11357-014-9656-x · Human clinical research

  3. Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease.

    Alimentary pharmacology & therapeutics · June 1, 1993 · Randomized controlled trial · cited 24 times

    PMID 8364132 · DOI 10.1111/j.1365-2036.1993.tb00098.x · Human clinical research

  4. Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans.

    Journal of neuroimmunology · March 1, 2000 · Other clinical trial · cited 62 times · open access

    PMID 10696913 · DOI 10.1016/s0165-5728(99)00237-4 · Human clinical research

  5. Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency.

    Journal of endocrinological investigation · October 1, 1996 · Other clinical trial · cited 15 times

    PMID 8957749 · DOI 10.1007/bf03349030 · Human clinical research

  6. Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters.

    Journal of intellectual disability research : JIDR · April 1, 1994 · Other clinical trial · cited 61 times

    PMID 8193451 · DOI 10.1111/j.1365-2788.1994.tb00370.x · Human clinical research

  7. Modulation of the neuroendocrine system and immune functions by zinc supplementation in children with Down's syndrome.

    Journal of trace elements and electrolytes in health and disease · December 1, 1993 · Other clinical trial · cited 20 times

    PMID 8019155 · Human clinical research

  8. Zinc deficiency in elderly patients.

    Nutrition (Burbank, Los Angeles County, Calif.) · May 1, 1993 · Other clinical trial · cited 244 times

    PMID 8353362 · Human clinical research

  9. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population.

    The American journal of clinical nutrition · April 1, 1993 · Other clinical trial · cited 137 times

    PMID 8460613 · DOI 10.1093/ajcn/57.4.566 · Human clinical research

  10. Zinc affects the metabolism of thyroid hormones in children with Down's syndrome: normalization of thyroid stimulating hormone and of reversal triiodothyronine plasmic levels by dietary zinc supplementation.

    The International journal of neuroscience · July 1, 1992 · Other clinical trial · cited 62 times

    PMID 1341688 · DOI 10.3109/00207459209003299 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Serum thymulin in human zinc deficiency.

    The Journal of clinical investigation · October 1, 1988 · Other clinical trial · cited 335 times · open access

    PMID 3262625 · DOI 10.1172/jci113717 · Human clinical research

  2. Contribution of zinc and other metals to the biological activity of the serum thymic factor.

    Proceedings of the National Academy of Sciences of the United States of America · September 1, 1982 · Animal study · cited 311 times · open access

    PMID 6957870 · DOI 10.1073/pnas.79.17.5370 · Animal studies

  3. Zinc deficiency in elderly patients.

    Nutrition (Burbank, Los Angeles County, Calif.) · May 1, 1993 · Other clinical trial · cited 244 times

    PMID 8353362 · Human clinical research

  4. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus?

    Lancet (London, England) · May 1, 1984 · Observational human study · cited 156 times

    PMID 6143966 · DOI 10.1016/s0140-6736(84)92325-0 · Human clinical research

  5. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells.

    The Journal of clinical endocrinology and metabolism · July 1, 1992 · In vitro study · cited 155 times

    PMID 1619008 · DOI 10.1210/jcem.75.1.1619008 · In vitro studies

Latest publications

  1. Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy.

    Nature communications · July 21, 2026 · Animal study · cited 1 times · open access

    PMID 42481458 · DOI 10.1038/s41467-026-75383-0 · Animal studies

  2. Protective effect of exogenous peroxiredoxin 6 and thymic peptide thymulin on BBB conditions in an experimental model of multiple sclerosis.

    Archives of biochemistry and biophysics · August 24, 2023 · Animal study · cited 6 times

    PMID 37633587 · DOI 10.1016/j.abb.2023.109729 · Animal studies

  3. Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice.

    International journal of immunopathology and pharmacology · January 1, 2021 · Animal study · cited 14 times · open access

    PMID 33779346 · DOI 10.1177/20587384211005645 · Animal studies

  4. Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma.

    Science advances · June 10, 2020 · Animal study · cited 45 times · open access

    PMID 32577505 · DOI 10.1126/sciadv.aay7973 · Animal studies

  5. Comparison of Thymulin Activity with Other Measures of Marginal Zinc Deficiency.

    Biological trace element research · May 3, 2020 · Animal study · cited 11 times

    PMID 32363520 · DOI 10.1007/s12011-020-02159-y · Animal studies

  6. Protective Effect of PBCA Nanoparticles Loaded with Thymulin Against the Relapsing-Remitting Form of Experimental Autoimmune Encephalomyelitis in Mice.

    International journal of molecular sciences · October 29, 2019 · Animal study · cited 12 times · open access

    PMID 31671728 · DOI 10.3390/ijms20215374 · Animal studies

  7. Prenatal and childhood exposures are associated with thymulin concentrations in young adolescent children in rural Nepal.

    Journal of developmental origins of health and disease · September 2, 2019 · Randomized controlled trial · cited 4 times

    PMID 31475652 · DOI 10.1017/s2040174419000485 · Human clinical research

  8. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways.

    International immunopharmacology · March 6, 2019 · Animal study · cited 18 times

    PMID 30851702 · DOI 10.1016/j.intimp.2019.02.042 · Animal studies

  9. Targeting inflammatory components in neuropathic pain: The analgesic effect of thymulin related peptide.

    Neuroscience letters · November 29, 2018 · Review · cited 27 times

    PMID 30503917 · DOI 10.1016/j.neulet.2018.11.041 · Reviews and meta-analyses

  10. Thymulin, free or bound to PBCA nanoparticles, protects mice against chronic septic inflammation.

    PloS one · May 24, 2018 · Animal study · cited 16 times · open access

    PMID 29795607 · DOI 10.1371/journal.pone.0197601 · Animal studies

Browse all 324 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Facteur thymique serique; Thymulin; Thymuline

((TITLE_ABS:"Facteur thymique serique" OR CHEM:"Facteur thymique serique") OR (TITLE_ABS:"Thymulin" OR CHEM:"Thymulin") OR (TITLE_ABS:"Thymuline" OR CHEM:"Thymuline")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Thymulin research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/thymulin